Gabelli & Co Investment Advisers’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,896	Closed	-$6.53K	–	298
2022 Q4	$6.53K	Hold	21,896	–	–	﹤0.01%	226
2022 Q3	$2K	Hold	21,896	–	–	﹤0.01%	423
2022 Q2	$3K	Hold	21,896	–	–	﹤0.01%	455
2022 Q1	$4K	Hold	21,896	–	–	﹤0.01%	503
2021 Q4	$13K	Hold	21,896	–	–	﹤0.01%	467
2021 Q3	$14K	Buy	+21,896	New	+$17K	﹤0.01%	462

Gabelli & Co Investment Advisers's EBACW Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 21,896 shares — an estimated $6.53K sold.

Gabelli & Co Investment Advisers first reported a position in EBACW in Q3 2021 and held it in 6 quarters. The position peaked at $14K in Q3 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Gabelli & Co Investment Advisers reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 21,896 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $6.53K.
Gabelli & Co Investment Advisers first reported a position in European Biotech Acquisition Corp. Warrant in Q3 2021 and held it in 6 quarters.
Gabelli & Co Investment Advisers's European Biotech Acquisition Corp. Warrant position peaked at $14K in Q3 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.